Clinical Trial to Improve the Magnetic Levator Prosthesis

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
BlepharoptosisPtosis, EyelidMyasthenia GravisStrokeTraumatic Brain Injury
Interventions
DEVICE

Magnetic Levator Prosthesis (MLP)

Neodymium magnet embedded in a glasses frame and a polymer embedded (PDMS) micro-magnet array fitted externally to the upper lid with IV 3000 securement film. The IV 3000 is FDA approved for extended wear on the skin. Tegaderm, which is essentially the same adhesive, is even FDA approved as an eye covering (we used Tegaderm in early studies but switched to IV 3000 for its superior ease of handling based on packaging technique).

Trial Locations (1)

02114

Schepens Eye Research Institute, Boston

All Listed Sponsors
lead

Massachusetts Eye and Ear Infirmary

OTHER

NCT03818204 - Clinical Trial to Improve the Magnetic Levator Prosthesis | Biotech Hunter | Biotech Hunter